Condition category
Infections and Infestations
Date applied
30/09/2004
Date assigned
30/09/2004
Last edited
18/07/2016
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr N V Naoumov

ORCID ID

Contact details

General Medicine (Hepatology)
Institute of Hepatology
University College London
69-75 Chenies Mews
London
WC1E 6HX
United Kingdom
+44 (0)20 7388 2013
n.naoumov@ucl.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0263132921

Study information

Scientific title

Analysis of the duration of combination therapy that is necessary for hepatitis C (HCV) genotype 1 eradication

Acronym

Study hypothesis

What is the duration of combination therapy required in order to produce a sustained viral clearance in hepatitis C infected patients

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use contact details to request a participant information sheet

Condition

Infections and Infestations: Hepatitis C

Intervention

Randomised Controlled Trial
1. Chemotherapy 1
2. Chemotherapy 2

Intervention type

Drug

Phase

Not Applicable

Drug names

Primary outcome measures

Viral clearance

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/10/2003

Overall trial end date

01/10/2005

Reason abandoned

Eligibility

Participant inclusion criteria

50 patients from Hepatology

Participant type

Patient

Age group

Not Specified

Gender

Both

Target number of participants

50

Participant exclusion criteria

Does not match inclusion criteria

Recruitment start date

01/10/2003

Recruitment end date

01/10/2005

Locations

Countries of recruitment

United Kingdom

Trial participating centre

University College London
London
WC1E 6HX
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Funder name

University College London Hospitals NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes

18/07/2016: No publications found, verifying study status with principal investigator.